YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis

Xin Zhou1, Weiyun Li1, Shuang Wang1

  • 1State Key Laboratory of Cell Biology, Key Laboratory of Systems Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Innovation Center for Cell Signaling Network, Shanghai 200031, China.

Cell Reports
|April 25, 2019
PubMed

Insights

Yes-associated protein (YAP) in macrophages worsens inflammatory bowel disease (IBD) by promoting M1 macrophage activation and altering gut microbiota, despite its known role in epithelial repair.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Inflammatory bowel disease (IBD) involves complex immune dysregulation, including inflammation, macrophage polarization, and gut microbial imbalance.
  • The Hippo pathway component Yes-associated protein (YAP) is implicated in epithelial regeneration, potentially aiding IBD recovery.
  • The specific role of YAP in macrophage function and its impact on IBD pathogenesis remain incompletely understood.

Purpose of the Study:

  • To investigate the role of YAP in macrophage polarization, inflammation, and gut microbial homeostasis in the context of IBD.
  • To elucidate how YAP influences different macrophage activation states (M1 vs. M2) and their associated cytokine production.
  • To determine the net effect of YAP in macrophages on IBD progression.

Main Methods:

  • Investigated YAP's role in macrophage polarization using in vitro models of M1 and M2 activation.
  • Analyzed YAP's impact on cytokine production, including IL-6, IL-4, and IL-13.
  • Assessed YAP's effects on antimicrobial peptide production and gut microbiota composition in IBD models.
  • Examined YAP expression patterns during M1 and M2 macrophage differentiation.

Main Results:

  • YAP expression in macrophages exacerbates IBD, contrary to its beneficial role in epithelial cells.
  • YAP impairs M2 macrophage polarization induced by IL-4/IL-13.
  • YAP promotes M1 macrophage activation triggered by LPS/IFN-γ, leading to increased IL-6 production.
  • YAP influences the production of antimicrobial peptides and alters gut microbial composition in IBD.

Conclusions:

  • YAP plays a detrimental role in IBD when expressed in macrophages, promoting pro-inflammatory M1 phenotypes.
  • Understanding YAP's context-dependent functions in different cell types is critical for developing effective IBD therapies.
  • Targeting YAP in specific immune cells may offer a novel therapeutic strategy for IBD.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1000
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
943
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
483
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
556
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
663
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.0K